Enforcers' Roundtable: American Bar Association Section of Antitrust Law 70th Annual Spring Meeting Marriot Marquis, Washington, DC Friday, April 8, 2022.

The states are also still working on a number of other pharmaceutical cases: the states' Subox-one product-hopping case that I lead and the price-fixing cases against the generic drugs industry led by a team from Connecticut, New York, and Florida, amongst others. Section Chair & Moderator; Arnold & Porter Kaye Scholer LLP, Washington, DC QUESTIONER Melanie L. Aitken Bennett Jones (US) LLP, Washington, DC SPEAKERS Gwendolyn J. Cooley NAAG Representative, Office of the Attorney General, Madison, WI Alexandre Cordeiro Macedo President, Conselho Administrativo De Defesa Economica (CADE), Brasilia Hon. Jonathan S. Kanter Assistant Attorney General, U.S. Department of Justice, Antitrust Division, Washington, DC Hon. Lina M. Khan Chair, Federal Trade Commission, Washington, DC Margrethe Vestager Executive Vice President & Commissioner, European Commission, Brussels JONATHAN GLEKLEN: Welcome, everybody, to the Enforcers' Roundtable, always a highlight of the Spring Meeting, and this year is no exception. My guess is a number of U.S. companies, maybe a couple of Chinese companies, maybe a couple of European companies as well. One week later that same company notified CADE about buying another company that had another dam in the same city. There are also consumer tech cases, like the New Mexico settlement with Google over Children's Online Privacy Protection Act violations; and Attorneys General from D.C., Indiana, Texas, and Washington also have another litigation against Google for its location-tracking practices and -- my favorite phrase -- dark patterns. [Extracted from the article]